Disparities in Pancreatic Ductal Adenocarcinoma-The Significance of Hispanic Ethnicity, Subgroup Analysis, and Treatment Facility on Clinical Outcomes

被引:18
|
作者
Riner, Andrea N. [1 ]
Underwood, Patrick W. [1 ]
Yang, Kai [2 ]
Herremans, Kelly M. [1 ]
Cameron, Miles E. [1 ,3 ]
Chamala, Srikar [4 ]
Qiu, Peihua [2 ]
George, Thomas J. [5 ]
Permuth, Jennifer B. [6 ,7 ]
Merchant, Nipun B. [8 ]
Trevino, Jose G. [1 ]
机构
[1] Univ Florida, Dept Surg, Coll Med, 1600 SW Archer Rd,POB 100109, Gainesville, FL 32610 USA
[2] Univ Florida, Dept Biostat, Coll Med, Gainesville, FL 32610 USA
[3] Univ Florida, Dept Phys Therapy, Coll Med, Gainesville, FL 32610 USA
[4] Univ Florida, Dept Pathol Immunol & Lab Med, Coll Med, Gainesville, FL 32610 USA
[5] Univ Florida, Dept Med, Coll Med, Div Hematol & Oncol, Gainesville, FL 32610 USA
[6] H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Epidemiol, Tampa, FL USA
[7] H Lee Moffitt Canc Ctr & Res Inst, Dept Gastrointestinal Oncol, Tampa, FL USA
[8] Univ Miami, Coll Med, Dept Surg, Miami, FL USA
来源
CANCER MEDICINE | 2020年 / 9卷 / 12期
基金
美国国家卫生研究院;
关键词
pancreatic ductal adenocarcinoma; survival; RACIAL DISPARITIES; CANCER; SURVIVAL;
D O I
10.1002/cam4.3042
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Disparities exist among patients with pancreatic ductal adenocarcinoma (PDAC). Non-White race is regarded as a negative predictor of expected treatment and overall survival. Data suggest that Academic Research Programs (ARP) provide better outcomes for minorities, but ethnic/minority outcomes are underreported. We hypothesize that outcomes among racially/ethnically diverse PDAC patients may be influenced by treatment facility. Methods The National Cancer Database was used to identify 170,327 patients diagnosed with PDAC between 2004 and 2015. Cox proportional-hazard regression was used to compare survival between race/ethnic groups across facilities. Results In unadjusted models, compared to non-Hispanic Whites (NHW), non-Hispanic Blacks (NHB) had the worst overall survival (HR = 1.05, 95%CI: 1.03-1.06, P < .001) and Hispanics had the best overall survival (HR = 0.92, 95%CI: 0.90-0.94, P < .001). After controlling for socioeconomic and clinical covariates, NHB (HR = 0.95, 95%CI: 0.93-0.96, P < .001) had better overall survival compared to NHW, and Hispanics continued to have the best comparative outcomes (HR = 0.84, 95%CI: 0.82-0.86, P < .001). Among Hispanics, Dominicans and South/Central Americans lived the longest, at 10.25 and 9.82 months, respectively. The improved survival in Hispanics was most pronounced at ARP (HR = 0.80, 95%CI: 0.77-0.84, P < .001) and Integrated Network Cancer Programs (HR = 0.78, 95%CI: 0.73-0.84, P < .001). NHB had improved survival over NHW at Comprehensive Community Care Programs (HR = 0.96, 95%CI: 0.93-0.98, P = .002) and ARP (HR = 0.96, 95%CI: 0.94-0.98, P = .001), which was influenced by income, education, and surgical resection. Conclusion Survival was improved at ARP for all populations. Hispanics had the best comparative overall survival. NHB had improved overall survival at higher volume centers, but this was dependent upon income, education, and surgical resection.
引用
收藏
页码:4069 / 4082
页数:14
相关论文
共 50 条
  • [1] Disparities in pancreatic ductal adenocarcinoma - the significance of Hispanic ethnicity, by subgroup analysis, and treatment facility on clinical outcomes
    Riner, Andrea N.
    Underwood, Patrick W.
    Yang, Kai
    Herremans, Kelly M.
    Cameron, Miles E.
    Chamala, Srikar
    Qiu, Peihua
    George, Thomas
    Permuth, Jennifer
    Merchant, Nipun B.
    Trevino, Jose G.
    CANCER RESEARCH, 2020, 80 (16)
  • [2] Analysis of clinical significance of BRCAness in pancreatic ductal adenocarcinoma
    Tadehara, Masayoshi
    Kato, Takuya
    Adachi, Kai
    Sakurai, Yasutaka
    Ichinoe, Masaaki
    Murakumo, Yoshiki
    CANCER SCIENCE, 2021, 112 : 810 - 810
  • [3] Analysis of the clinical and biological significance of CD109 in pancreatic ductal adenocarcinoma
    Adachi, Kai
    Sakurai, Yasutaka
    Kato, Takuya
    Ichinoe, Masaaki
    Murakumo, Yoshiki
    CANCER SCIENCE, 2022, 113 : 569 - 569
  • [4] Racial Disparities in the Treatment of Resectable Pancreatic Ductal Adenocarcinoma: A Propensity Score Matched Analysis
    Farah, Emile
    Abreu, Andres A.
    Rail, Benjamin
    Wang, Sam C.
    Porembka, Matthew R.
    Mansour, John C.
    Yopp, Adam C.
    Zeh, Herbert J., III
    Polanco, Patricio M.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2023, 237 (05) : S461 - S462
  • [5] Expression and clinical significance of apolipoprotein E in pancreatic ductal adenocarcinoma
    Jiong Chen
    Long-Jiang Chen
    Ren-Bao Yang
    Yun-Lian Xia
    Hang-Cheng Zhou
    Wen Wu
    Yin Lu
    Li-Wei Hu
    Yue Zhao
    Medical Oncology, 2013, 30
  • [6] Clinical significance of RECK promoter methylation in pancreatic ductal adenocarcinoma
    Lu, Xiong-Xiong
    Zhang, Shu-Min
    Fang, Yuan
    Wang, Zheng-Ting
    Xie, Jun-Jie
    Zhan, Qian
    Deng, Xia-Xing
    Chen, Hao
    Jin, Jia-Bin
    Peng, Cheng-Hong
    Li, Hong-Wei
    Shen, Bai-Yong
    TUMOR BIOLOGY, 2013, 34 (06) : 3339 - 3343
  • [7] Clinical significance of MUC13 in pancreatic ductal adenocarcinoma
    Khan, Sheema
    Zafar, Nadeem
    Khan, Shabia S.
    Setua, Saini
    Behrman, Stephen W.
    Stiles, Zachary E.
    Yallapu, Murali M.
    Sahay, Peeyush
    Ghimire, Hemendra
    Ise, Tomoko
    Nagata, Satoshi
    Wang, Lei
    Wan, Jim Y.
    Pradhan, Prabhakar
    Jaggi, Meena
    Chauhan, Subhash C.
    HPB, 2018, 20 (06) : 563 - 572
  • [8] Expression and clinical significance of apolipoprotein E in pancreatic ductal adenocarcinoma
    Chen, Jiong
    Chen, Long-Jiang
    Yang, Ren-Bao
    Xia, Yun-Lian
    Zhou, Hang-Cheng
    Wu, Wen
    Lu, Yin
    Hu, Li-Wei
    Zhao, Yue
    MEDICAL ONCOLOGY, 2013, 30 (02)
  • [9] Clinical significance of serum survivin in patients with pancreatic ductal adenocarcinoma
    Ren, Y-Q.
    Zhang, H-Y.
    Su, T.
    Wang, X-H.
    Zhang, L.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2014, 18 (20) : 3063 - 3068
  • [10] Clinical significance of cathepsin E in pancreatic juice in the diagnosis of pancreatic ductal adenocarcinoma
    Uno, K
    Azuma, T
    Nakajima, M
    Yasuda, K
    Hayakumo, T
    Mukai, H
    Sakai, T
    Kawai, K
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2000, 15 (11) : 1333 - 1338